Zincoderm-S Ointment is a topical formulation containing Clobetasol propionate (0.05% w/w), Zinc oxide (2.5% w/w), and Salicylic acid (3% w/w), designed for the management of various inflammatory and hyperkeratotic dermatological conditions. Clobetasol propionate, a potent corticosteroid, exerts strong anti-inflammatory, antipruritic, and vasoconstrictive effects, effectively reducing erythema, swelling, and irritation associated with dermatoses such as psoriasis, eczema, and lichen planus. Zinc oxide provides a protective barrier with mild astringent and antiseptic properties, promoting skin healing and preventing secondary infections. Salicylic acid acts as a keratolytic agent, facilitating the removal of scales and enhancing the penetration of corticosteroids through hyperkeratotic lesions. The combined action of these ingredients makes Zincoderm-S particularly suitable for thick, scaly plaques and chronic inflammatory skin disorders. It is intended for external use only and should be applied in a thin layer to the affected area as directed by a healthcare professional. Prolonged use or application over large body areas should be avoided to minimize potential systemic absorption and adverse effects. Patients should be advised to avoid contact with eyes and mucous membranes and discontinue use if irritation occurs. Zincoderm-S Ointment offers a comprehensive approach to managing complex dermatological conditions requiring anti-inflammatory, protective, and keratolytic therapy.